Zydus Lifesciences informs about press releases

20 Feb 2023 Evaluate

Zydus Lifesciences has informed that it enclosed two press releases, both dated February 20, 2023 titled ‘Zydus receives tentative approval from the USFDA for Gabapentin Tablets (Once-Daily), 300 mg and 600 mg’ and ‘Zydus receives tentative approval from the USFDA for Canagliflozin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×